WePeptideRx vs Enhance MD
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
WePeptideRx
Best for premixed ready-to-inject GLP-1 with microdose protocol optionsStarting at $189/mo
Enhance MD
Best for lab-monitored compounded GLP-1 with mandatory video visitStarting at $49/mo
Side-by-Side Comparison
| Feature | WePeptideRx | Enhance MD |
|---|---|---|
| Overall Score | 7.0/10 | ✓8.6/10 |
| Starting Price | $189/mo | ✓$49/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.3 ★ /5 |
| Features | ✓8 features | 6 features |
| States Available | 0 | ✓39 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | ✓ Yes | — |
| FDA Warnings | None | None |
Pros & Cons
WePeptideRx
Pros
- ✓Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
- ✓Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
- ✓12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
- ✓Physical Boca Raton address, phone, and business hours listed
- ✓LegitScript Certified and publishes the FDA disclaimer
- ✓HSA/FSA accepted (uncommon for DTC compounded GLP-1)
Cons
- ✗Pharmacy partner not named
- ✗48-state claim, but the specific state list isn't shown on the homepage
- ✗Medical director not named on the homepage
- ✗Telemedicine is outsourced to a third-party provider network rather than in-house staff
- ✗Corporate legal entity and arbitration venue not disclosed
- ✗Microdose tiers require understanding sub-therapeutic dosing — verify clinical fit
Enhance MD
Pros
- ✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
- ✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
- ✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
- ✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
- ✓Low first-month intro pricing: $49 Core, $99 Advanced, $189 Elite
- ✓Unlimited clinician messaging and dose-adjustment support included
Cons
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
- ✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
- ✗No insurance accepted — cash pay, HSA/FSA eligible
- ✗Intro pricing resets to full tier rate after 30 days — the $49/$99/$189 figures aren't ongoing cost
Our Verdict
Enhance MD edges out WePeptideRx with a higher overall score of 8.6/10 and is particularly strong for lab-monitored compounded GLP-1 with mandatory video visit. WePeptideRx remains a solid alternative, especially if you're looking for premixed ready-to-inject GLP-1 with microdose protocol options.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring WePeptideRx and Enhance MD head-to-heads in the same category.
- WePeptideRx vs CoreAge Rx
- WePeptideRx vs TrimRx
- WePeptideRx vs Amazon One Medical
- Enhance MD vs NovoCare Pharmacy
- Enhance MD vs Vytora Health
- Enhance MD vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.